BioReperia
Anna Fahlgren has a diverse and extensive work experience. Anna is currently working as the Verksamhetsledare at East Sweden Medtech since November 2020. Prior to this role, they were a Professor in Cell Biology and Experimental Orthopaedics at Linköpings universitet since November 2013. Anna also held the position of Associate Professor in Experimental Orthopaedics at the same institution from November 2013 to November 2020. Anna Fahlgren is a Co-Founder of BioReperia, a company that provides unique services for drug discovery, since September 2015. Before that, they worked as an Assistant Scientist at the Hospital for Special Surgery from 2010 to November 2021. Anna was also a Lecturer in Regenerative Medicine and a Marie Curie VINNMER Fellow at Linköping University from 2004 to 2021. In addition, Anna Fahlgren worked as a Consultant at AddScience from 2009 to November 2021 and served as a Board Member at LiU Holding AB from 2007 to November 2021. Anna also had a Post-doctoral fellowship at the Swedish Society of Medical Research from 2008 to 2010.
Anna Fahlgren has pursued a Master of Science in Pharmacology at Linköping University. Additionally, they have completed a PhD program in Sports Medicine at the same institution. Specific start and end years for these programs are not provided.
This person is not in the org chart
This person is not in any teams
BioReperia
1 followers
BioReperia is located at Linköpings University. Their researchers have more than 10 years experience developing and using zebrafish models for medical research including toxicology and tumor biology. Their models are today widely used in both academic and industrial research and drug development projects around the globe.